Summary:
Help us with diabetes insulin research
Type 2 Diabetes
A 15 month clinical research study is evaluating if a new investigational basal insulin dosed once daily can provide safe and effective blood sugar control compared to a marketed basal insulin dosed once daily in people with type 2 diabetes.
Qualified participants will receive all study related care and study medication at no cost and may be compensated for travel.
Qualified Participants Must:
• Be18 years of age, or older
•
Have had a diagnosis of type 2 diabetes for at least 6 months
•
Be receiving treatment with any basal insulin with or without oral antidiabetic drugs for at least 6 months
•
Be at high risk for developing hypoglycemia (i.e. recent hypoglycemic episode, severe hypoglycemic episode, hypoglycemic unawareness, moderate chronic renal failure or insulin usage for more than 5 years)
•
Have an HbA1c level of not more than 9.5%
•Have a body mass index (BMI) of less than 45 kg/m2
Qualified Participants May Receive:
All study related care and study medication at no cost and possible compensation for travel.